Tavenier, A. H., Hermanides, R. S., Fabris, E., Angiolillo, D. J., & van't Hof, A. W. J. (2021). Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI. International Journal of Cardiology, 328, 40-45. https://doi.org/10.1016/j.ijcard.2020.11.042

Opacic, D., van Hunnik, A., Zeemering, S., Dhalla, A., Belardinelli, L., Schotten, U., & Verheule, S. (2021). Electrophysiological effects of ranolazine in a goat model of lone atrial fibrillation. Heart Rhythm, 18(4), 615-622. https://doi.org/10.1016/j.hrthm.2020.11.021

Mulder, B. A., Luermans, J. G. L. M., Hindricks, G., & Blaauw, Y. (2021). Innovations and paradigm shifts in atrial fibrillation ablation. EP Europace, 23, II23-II27. https://doi.org/10.1093/europace/euaa418

Heijman, J., Vernooy, K., & C van Gelder, I. (2021). The road goes ever on: innovations and paradigm shifts in atrial fibrillation management. EP Europace, 23, II1-II3. https://doi.org/10.1093/europace/euab061

van Rosmalen, F., Delhaas, T., Dagres, N., Arbelo, E., Blomstrom-Lundqvist, C., Crijns, H. J. G. M., Da Costa, A., Pytkowski, M., Sharikov, N., Laroche, C., Tavazzi, L., Brugada, J., Pison, L., & ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators (2021). Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry. Journal of Interventional Cardiac Electrophysiology, 60(3), 395-406. https://doi.org/10.1007/s10840-020-00744-8

Linz, D., & Dobrev, D. (2021). A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic. IJC Heart and Vasculature, 33, Article 100749. https://doi.org/10.1016/j.ijcha.2021.100749

Maesen, B., Luermans, J. G. L. M., Bidar, E., Chaldoupi, S.-M., Gelsomino, S., Maessen, J. G., Pison, L., & La Meir, M. (2021). A hybrid approach to complex arrhythmias. EP Europace, 23, ii28-ii33. https://doi.org/10.1093/europace/euab027

Nedios, S., Sanatkhani, S., Oladosu, M., Seewoester, T., Richter, S., Arya, A., Heijman, J., Crijns, H. J. G. M., Hindricks, G., Bollmann, A., & Menon, P. G. (2021). Association of low-voltage areas with the regional wall deformation and the left atrial shape in patients with atrial fibrillation: A proof of concept study. IJC Heart & Vasculature, 33, Article 100730. https://doi.org/10.1016/j.ijcha.2021.100730

Claassens, D. M. F., Bergmeijer, T. O., Vos, G. J. A., Hermanides, R. S., 't Hof, A. W. J. V., van der Harst, P., Barbato, E., Morisco, C., Gin, R. M. T. J., Asselbergs, F. W., Mosterd, A., Herrman, J.-P. R., Dewilde, W. J. M., Janssen, P. W. A., Kelder, J. C., Mahmoodi, B. K., Deneer, V. H. M., & ten Berg, J. M. (2021). Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis. Circulation-Cardiovascular Interventions, 14(4), 402-411. Article 009434. https://doi.org/10.1161/circinterventions.120.009434

Vink, A. S., Hermans, B. J. M., Pimenta, J., Peltenburg, P. J., Filippini, L. H. P. M., Hofman, N., Clur, S.-A. B., Blom, N. A., Wilde, A. A. M., Delhaas, T., & Postema, P. G. (2021). Diagnostic accuracy of the response to the brief tachycardia provoked by standing in children suspected for long QT syndrome. Heart Rhythm O2, 2(2), 149-159. https://doi.org/10.1016/j.hroo.2021.03.005

Linz, D., Hermans, A., & Tieleman, R. G. (2021). Early atrial fibrillation detection and the transition to comprehensive management. EP Europace, 23, II46-II51. https://doi.org/10.1093/europace/euaa424

Snoek, J. A., Prescott, E. I., van der Velde, A. E., Eijsvogels, T. M. H., Mikkelsen, N., Prins, L. F., Bruins, W., Meindersma, E., Gonzalez-Juanatey, J. R., Pena-Gil, C., Gonzalez-Salvado, V., Moatemri, F., Iliou, M. C., Marcin, T., Eser, P., Wilhelm, M., Van't Hof, A. W. J., & de Kluiver, E. P. (2021). Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe: A Randomized Clinical Trial. JAMA Cardiology, 6(4), 463-468. https://doi.org/10.1001/jamacardio.2020.5218

Marchal, S., van 't Hof, A. W., Bilo, H. J., Deijns, S. J., Heeg, J. E., Schoenmakers, M., Schouwink, M., Schwantje, O., Bots, M. L., Hoes, A. W., & Hollander, M. (2021). Integrated cardiovascular risk management programme versus usual care in patients at high cardiovascular risk: an observational study in general practice. BJGP Open, 5(2), Article 0099. https://doi.org/10.3399/BJGPO.2020.0099

Geraets, I. M. E., Coumans, W. A., Strzelecka, A., Schonleitner, P., Antoons, G., Schianchi, F., Willemars, M. M. A., Kapsokalyvas, D., Glatz, J. F. C., Luiken, J. J. F. P., & Nabben, M. (2021). Metabolic Interventions to Prevent Hypertrophy-Induced Alterations in Contractile Properties In Vitro. International journal of molecular sciences, 22(7), Article 3620. https://doi.org/10.3390/ijms22073620

Linz, D., Linz, B., Homberg, M., Bouman, E., Dobrev, D., Hendriks, J. M., & Simons, S. O. (2021). Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation. IJC Heart and Vasculature, 33, Article 100783. https://doi.org/10.1016/j.ijcha.2021.100783

Schotten, U., Lee, S., Zeemering, S., & Waldo, A. L. (2021). Paradigm shifts in electrophysiological mechanisms of atrial fibrillation. EP Europace, 23, II9-II13. https://doi.org/10.1093/europace/euaa384

Pezzuto, S., Prinzen, F. W., Potse, M., Maffessanti, F., Regoli, F., Caputo, M. L., Conte, G., Krause, R., & Auricchio, A. (2021). Reconstruction of three-dimensional biventricular activation based on the 12-lead electrocardiogram via patient-specific modelling. EP Europace, 23(4), 640-647. https://doi.org/10.1093/europace/euaa330

Verhaert, D. V. M., Brunner-La Rocca, H.-P., van Veldhuisen, D. J., & Vernooy, K. (2021). The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases. EP Europace, 23, II40-II45. https://doi.org/10.1093/europace/euaa368

Betz, K., Knuf, F., Duncker, D., Giordano, M., Dobrev, D., & Linz, D. (2021). The impact of Twitter promotion on future citation rates: The #TweetTheJournal study. IJC Heart and Vasculature, 33, Article 100776. https://doi.org/10.1016/j.ijcha.2021.100776

Heijman, J., Ghossein, M. A., Vernooy, K., & Linz, D. (2021). The walk of life: Remote monitoring provides insights into physical activity during a pandemic. IJC Heart and Vasculature, 33, Article 100772. https://doi.org/10.1016/j.ijcha.2021.100772

Coronel, R., Potse, M., Haïssaguerre, M., Derval, N., Rivaud, M. R., Meijborg, V. M. F., Cluitmans, M., Hocini, M., & Boukens, B. J. (2021). Why Ablation of Sites With Purkinje Activation Is Antiarrhythmic: The Interplay Between Fast Activation and Arrhythmogenesis. Frontiers in physiology, 12, Article 648396. https://doi.org/10.3389/fphys.2021.648396

van Cauteren, Y. J. M., Smulders, M. W., Theunissen, R. A. L. J., Gerretsen, S. C., Adriaans, B. P., Bijvoet, G. P., Mingels, A. M. A., van Kuijk, S. M. J., Schalla, S., Crijns, H. J. G. M., Kim, R. J., Wildberger, J. E., Heijman, J., & Bekkers, S. C. A. M. (2021). Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial. Journal of Cardiovascular Magnetic Resonance, 23(1), Article 40. https://doi.org/10.1186/s12968-021-00723-6

Krammer, C., Kontos, C., Dewor, M., Hille, K., Dalla Volta, B., El Bounkari, O., Tas, K., Sinitski, D., Brandhofer, M., Megens, R. T. A., Weber, C., Schultz, J. R., Bernhagen, J., & Kapurniotu, A. (2021). A MIF-Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2. Chembiochem, 22(6), 1012-1019. https://doi.org/10.1002/cbic.202000574

Linz, D., Homberg, M., van der Velden, R. M. J., Bouman, E., Buhre, W., & Simons, S. O. (2021). Sleep apnea, obesity and COPD depress respiration during catheter ablation procedures: Implications for transcutaneous carbon dioxide monitoring. International Journal of Cardiology, 327, 102-104. https://doi.org/10.1016/j.ijcard.2020.10.080

van Rosmalen, F., Maesen, B., van Hunnik, A., Hermans, B. J. M., Bonizzi, P., Bidar, E., Nijs, J., Maessen, J. G., Verheule, S., Delhaas, T., Schotten, U., & Zeemering, S. (2021). Incidence, prevalence, and trajectories of repetitive conduction patterns in human atrial fibrillation. EP Europace, 23(Supplement_1), i123-i132. https://doi.org/10.1093/europace/euaa403

Mohseni, Z., Derksen, E., Oben, J., Al-Nasiry, S., Spaanderman, M. E. A., & Ghossein-Doha, C. (2021). Cardiac dysfunction after preeclampsia; an overview of pro- and anti-fibrotic circulating effector molecules. Pregnancy Hypertension, 23, 140-154. https://doi.org/10.1016/j.preghy.2020.12.001

de Vries, T. A. C., Hemels, M. E. W., Cools, F., Crijns, H. J. G. M., Yperzeele, L., Vanacker, P., Blankoff, I., Lancellotti, P., Mairesse, G. H., de Veer, A., Arroyo, R. C., Catez, E., de Pauw, M., Vanassche, T., de Asmundis, C., Kirchhof, P., De Caterina, R., de Groot, J. R., & ETNA-AF-Europe principal investigators from Belgium and the Netherlands (2021). Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study. Netherlands Heart Journal, 29(3), 158-167. https://doi.org/10.1007/s12471-020-01518-7

Heusinkveld, M. H. G., Holtackers, R. J., Adriaans, B. P., Op't Roodt, J., Arts, T., Delhaas, T., Reesink, K. D., & Huberts, W. (2021). Complementing sparse vascular imaging data by physiological adaptation rules. Journal of Applied Physiology, 130(3), 571-588. https://doi.org/10.1152/japplphysiol.00250.2019

van Stipdonk, A. M. W., Schretlen, S., Dohmen, W., Brunner-LaRocca, H. P., Knackstedt, C., & Vernooy, K. (2021). Development and implementation of a cardiac resynchronisation therapy care pathway: improved process and reduced resource use. BMJ Open Quality, 10(1), Article e001072. https://doi.org/10.1136/bmjoq-2020-001072

Jensen, M. T., Treskes, R. W., Caiani, E. G., Casado-Arroyo, R., Cowie, M. R., Dilaveris, P., Duncker, D., Di Rienzo, M., Frederix, I., De Groot, N., Kolh, P. H., Kemps, H., Mamas, M., McGreavy, P., Neubeck, L., Parati, G., Platonov, P. G., Schmidt-Trucksass, A., Schuuring, M. J., ... Lumens, J. (2021). ESC working group on e-cardiology position paper: Use of commercially available wearable technology for heart rate and activity tracking in primary and secondary cardiovascular prevention - In collaboration with the European Heart Rhythm Association, European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professionals, Patient Forum, and the Digital Health Committee. European Heart Journal - Digital Health, 2(1), 49-59. https://doi.org/10.1093/ehjdh/ztab011

Verzaal, N. J., Masse, S., Downar, E., Nanthakumar, K., Delhaas, T., & Prinzen, F. W. (2021). Exploring the cause of conduction delays in patients with repaired Tetralogy of Fallot. EP Europace, 23, I105-I112. https://doi.org/10.1093/europace/euaa400

Mellor, G. J., Blom, L. J., Groeneveld, S. A., Winkel, B. G., Ensam, B., Bargehr, J., van Rees, B., Scrocco, C., Krapels, I. P. C., Volders, P. G. A., Tfelt-Hansen, J., Krahn, A. D., Hassink, R. J., & Behr, E. R. (2021). Familial Evaluation in Idiopathic Ventricular Fibrillation: Diagnostic Yield and Significance of J Wave Syndromes. Circulation-Arrhythmia and Electrophysiology, 14(3), 296-305. Article 009089. https://doi.org/10.1161/CIRCEP.120.009089

Linz, D., Malfertheiner, M. V., Werner, N., Lerzer, C., Gfullner, F., Linz, B., Zeman, F., McEvoy, R. D., Arzt, M., & Baumert, M. (2021). Nocturnal hypoxemic burden during positive airway pressure treatment across different central sleep apnea etiologies. Sleep Medicine, 79, 62-70. https://doi.org/10.1016/j.sleep.2021.01.007

Fabris, E., ten Berg, J. M., Hermanides, R. S., Ottervanger, J. P., Dambrink, J. H. E., Gosselink, A. T. M., Sinagra, G., Koopmans, P. C., Giannitsis, E., Hamm, C., & Hof, A. W. J. V. (2021). NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial. American Heart Journal, 233, 78-85. https://doi.org/10.1016/j.ahj.2020.12.017

Ghossein, M. A., van Stipdonk, A. M. W., Plesinger, F., Kloosterman, M., Wouters, P. C., Salden, O. A. E., Meine, M., Maass, A. H., Prinzen, F. W., & Vernooy, K. (2021). Reduction in the QRS area after cardiac resynchronization therapy is associated with survival and echocardiographic response. Journal of Cardiovascular Electrophysiology, 32(3), 813-822. https://doi.org/10.1111/jce.14910

Gharaviri, A., Pezzuto, S., Potse, M., Conte, G., Zeemering, S., Sobota, V., Verheule, S., Krause, R., Auricchio, A., & Schotten, U. (2021). Synergistic antiarrhythmic effect of inward rectifier current inhibition and pulmonary vein isolation in a 3D computer model for atrial fibrillation. EP Europace, 23, I161-I168. https://doi.org/10.1093/europace/euaa413

Lubrecht, J. M., Grandits, T., Gharaviri, A., Schotten, U., Pock, T., Plank, G., Krause, R., Auricchio, A., Conte, G., & Pezzuto, S. (2021). Automatic reconstruction of the left atrium activation from sparse intracardiac contact recordings by inverse estimate of fibre structure and anisotropic conduction in a patient-specific model. EP Europace, 23, I63-I70. https://doi.org/10.1093/europace/euaa392

Lyon, A., van Mourik, M., Cruts, L., Heijman, J., Bekkers, S. C. A. M., Schotten, U., Crijns, H. J. G. M., Linz, D., & Lumens, J. (2021). Both beat-to-beat changes in RR-interval and left ventricular filling time determine ventricular function during atrial fibrillation. EP Europace, 23, I21-I28. https://doi.org/10.1093/europace/euaa387

Fabritz, L., Crijns, H. J. G. M., Guasch, E., Goette, A., Häusler, K. G., Kotecha, D., Lewalter, T., Meyer, C., Potpara, T. S., Rienstra, M., Schnabel, R. B., Willems, S., Breithardt, G., Camm, A. J., Chan, A., Chua, W., de Melis, M., Dimopoulou, C., Dobrev, D., ... Kirchhof, P. (2021). Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. EP Europace, 23(3), 329-344. https://doi.org/10.1093/europace/euaa279

van Osta, N., Kirkels, F., Lyon, A., Koopsen, T., van Loon, T., Cramer, M.-J., Teske, A. J., Delhaas, T., & Lumens, J. (2021). Electromechanical substrate characterization in arrhythmogenic cardiomyopathy using imaging-based patient-specific computer simulations. EP Europace, 23, I153-I160. https://doi.org/10.1093/europace/euaa407

Pluymaekers, N. A. H. A., Hermans, A. N. L., van der Velden, R. M. J., Gawalko, M., den Uijl, D. W., Buskes, S., Vernooy, K., Crijns, H. J. G. M., Hendriks, J. M., & Linz, D. (2021). Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF. EP Europace, 23(3), 345-352. https://doi.org/10.1093/europace/euaa201

Vaas, V., Fisser, C., Tafelmeier, M., Linz, D., & Arzt, M. (2021). Interaktionen schlafbezogener Atmungsstörungen mit Vorhofflimmern. Somnologie, 25(1), 38-44. https://doi.org/10.1007/s11818-020-00271-8

Hoedemaker, N. P. G., de Winter, R. J., Hof, A. V., Kolkman, E., & Damman, P. (2021). Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry. American Journal of Cardiovascular Drugs, 21(2), 219-229. https://doi.org/10.1007/s40256-020-00427-9

Hermans, B. J. M., Zink, M. D., van Rosmalen, F., Crijns, H. J. G. M., Vernooy, K., Postema, P., Pison, L., Schotten, U., & Delhaas, T. (2021). Pulmonary vein isolation in a real-world population does not influence QTc interval. EP Europace, 23, I48-I54. https://doi.org/10.1093/europace/euaa390

Linz, B., Hohl, M., Lang, L., Wong, D. W. L., Nickel, A. G., De La Torre, C., Sticht, C., Wirth, K., Boor, P., Maack, C., Speer, T., Jespersen, T., Schotten, U., Sanders, P., Bohm, M., & Linz, D. (2021). Repeated exposure to transient obstructive sleep apnea-related conditions causes an atrial fibrillation substrate in a chronic rat model. Heart Rhythm, 18(3), 455-464. https://doi.org/10.1016/j.hrthm.2020.10.011

Heijman, J., Luermans, J. G. L. M., Linz, D., van Gelder, I. C., & Crijns, H. J. G. M. (2021). Risk Factors for Atrial Fibrillation Progression. Cardiac Electrophysiology Clinics, 13(1), 201-209. https://doi.org/10.1016/j.ccep.2020.10.011

Linz, D., Nattel, S., Kalman, J. M., & Sanders, P. (2021). Sleep Apnea and Atrial Fibrillation. Cardiac Electrophysiology Clinics, 13(1), 87-94. https://doi.org/10.1016/j.ccep.2020.10.003

Moossdorff-Steinhauser, H. F. A., Berghmans, B. C. M., Spaanderman, M. E. A., & Bols, E. M. J. (2021). Urinary incontinence during pregnancy: prevalence, experience of bother, beliefs, and help-seeking behavior. International Urogynecology Journal, 32(3), 695-701. https://doi.org/10.1007/s00192-020-04566-0

Widowski, H., Reynaert, N. L., Ophelders, D. R. M. G., Hütten, M. C., Nikkels, P. G. J., Severens-Rijvers, C. A. H., Cleutjens, J. P. M., Kemp, M. W., Newnham, J. P., Saito, M., Usuda, H., Payne, M. S., Jobe, A. H., Kramer, B. W., Delhaas, T., & Wolfs, T. G. A. M. (2021). Sequential Exposure to Antenatal Microbial Triggers Attenuates Alveolar Growth and Pulmonary Vascular Development and Impacts Pulmonary Epithelial Stem/Progenitor Cells. Frontiers in medicine, 8, Article 614239. https://doi.org/10.3389/fmed.2021.614239

Heijman, J., Linz, D., & Schotten, U. (2021). Dynamics of Atrial Fibrillation Mechanisms and Comorbidities. Annual Review of Physiology, 83, 83-106. https://doi.org/10.1146/annurev-physiol-031720-085307